David Cimbaluk

David Cimbaluk is an Associate Professor in the Department of Pathology at Rush University's Rush Medical College, Chicago. His research focuses on kidney diseases, immunology, and molecular pathology, with a strong emphasis on podocyte function, inflammation pathways, and diagnostic methods for renal disorders. He has collaborated extensively on studies involving kidney disease mechanisms, autoimmune conditions like systemic lupus erythematosus, and novel therapeutic strategies for cancer and transplantation.

His work spans experimental models (e.g., mouse studies) and clinical applications, including the development of diagnostic techniques like fine-needle aspiration and spatialomic profiling. Key areas include CD11b receptor modulation, miRNA regulation in diabetic nephropathy, and the role of SuPAR in viral-induced proteinuria. He has also contributed to understanding genetic syndromes like Alport Syndrome and X-linked conditions.

• Education: Not explicitly stated in text, inferred to include advanced training in pathology and molecular biology.
• Publications: Over 30 peer-reviewed articles since 2005, focusing on nephrology, immunology, and diagnostic pathology.

His publications highlight interdisciplinary collaboration, with frequent co-authorship in journals like Nature Communications, JCI Insight, and Journal of Clinical Investigation. Research trends emphasize translational studies linking molecular mechanisms to clinical outcomes in renal and autoimmune diseases.

Notable contributions include defining SuPAR's role in kidney disease, developing the SeqStain spatial profiling method, and investigating miR-146a's role in diabetic glomerulopathy. Collaborations with institutions like the University of Chicago and international teams underscore his global impact.